Method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of pregnant woman
A technology for pregnant women's peripheral blood and nuclear red blood cells, which is applied in the field of non-invasive prenatal diagnosis to achieve efficient and high-specificity capture
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] according to figure 1 The illustrated embodiment of the present invention uses nanomaterials to separate fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis. First, chemical modification methods (MPTMS, GMBS and Streptavidin are used to process the nano-substrates in sequence for 1 hour, 45 Minutes and 6 hours), and then drop the antibody with biotin group onto the substrate, and the nanoparticle 200 is combined with the antibody 201 to prepare a nanoparticle substrate modified with specific antibodies. The method of separating fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis firstly enters the step of capturing fetal nucleated red blood cells in the peripheral blood of pregnant women S1100: the venous blood of the pregnant women whose gestational age is 12 weeks and 3 days is collected from the hospital and stored in In the blood collection tube wit...
Embodiment 2
[0036] according to figure 1 The illustrated embodiment of the present invention uses nanomaterials to separate fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis. First, chemical modification methods (MPTMS, GMBS and Streptavidin are used to process the nano-substrates in sequence for 1 hour, 45 Minutes and 6 hours), and then drop the antibody with biotin group onto the substrate, and the nanoparticle 200 is combined with the antibody 201 to prepare a nanoparticle substrate modified with specific antibodies. The method for separating fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis firstly enters the step of capturing fetal nucleated red blood cells in the peripheral blood of the pregnant women. S1100: The venous blood of the pregnant women whose gestational age is 17 weeks and 4 days is collected from the hospital and stored in In the blood collection tu...
Embodiment 3
[0038] according to figure 1 The illustrated embodiment of the present invention uses nanomaterials to separate fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis. First, chemical modification methods (MPTMS, GMBS and Streptavidin are used to process the nano-substrates in sequence for 1 hour, 45 Minutes and 6 hours), and then drop the antibody with biotin group onto the substrate, and the nanoparticle 200 is combined with the antibody 201 to prepare a nanoparticle substrate modified with specific antibodies. The method of separating fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis first enters the step of capturing fetal nucleated red blood cells in the peripheral blood of pregnant women S1100: the venous blood of the pregnant women whose gestational age is 28 weeks and 2 days is collected from the hospital and stored in In the blood collection tube with ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com